Publications found:
73,128
Sort by:
Premature Ejaculation - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
41 pages
Rotavirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
55 pages
Stroke - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
716 pages
Asthma - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
758 pages
Overactive Bladder - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
127 pages
Ulcerative Colitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
671 pages
Allergic Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
97 pages
Bronchiectasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
90 pages
Eosinophilic Esophagitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Eosinophilic Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
131 pages
Klebsiella pneumoniae Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
128 pages
Polycystic Kidney Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Polycystic Kidney Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Kidney Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
127 pages
Rosacea - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rosacea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
90 pages
Yellow Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
57 pages
Cystic Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
502 pages
Sickle Cell Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
271 pages
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
92 pages
Post Menopausal Osteoporosis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
129 pages
Rabies - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rabies (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
96 pages
Optic Neuritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Optic Neuritis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
48 pages
Oropharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
550 pages
Vitiligo - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
144 pages
Acinetobacter Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acinetobacter Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
192 pages
Cataract - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
40 pages
Gastric Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
2197 pages
Haemophilus influenzae Type B Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Haemophilus influenzae Type B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Haemophilus influenzae Type B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
69 pages
Inclusion Body Myositis (IBM) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
70 pages
Low Back Pain - Pipeline Review, H1 2020
US$ 2,000.00
... . The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
130 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
403 pages
Critical Limb Ischemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Critical Limb Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Critical Limb Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
153 pages
Japanese Encephalitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Japanese Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Japanese Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
46 pages
Corneal Neovascularization - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Corneal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
41 pages
Hepatitis D - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis D (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
95 pages
Pompe Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pompe Disease (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pompe Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
102 pages
Neurofibromatoses Type II - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neurofibromatoses Type II (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type II and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
44 pages
Binge Eating Disorder - Pipeline Review, H1 2020
US$ 2,000.00
... . The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
62 pages
Hairy Cell Leukemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hairy Cell Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hairy Cell Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
125 pages
Retinoblastoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinoblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Retinoblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
67 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
162 pages
Chronic Urticaria Or Hives - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Urticaria Or Hives (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
140 pages
Organophosphate and Carbamate Poisoning - Pipeline Review, H1 2020
US$ 2,000.00
... . The Organophosphate and Carbamate Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Organophosphate and Carbamate Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
38 pages
Pheochromocytoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pheochromocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pheochromocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
112 pages
Ureter Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ureter Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ureter Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
298 pages
Gastroenteritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastroenteritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastroenteritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
97 pages
Neisseria meningitidis Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neisseria meningitidis Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
93 pages
Keratitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keratitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
84 pages
Guillain-Barre Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Guillain-Barre Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
62 pages
Rett Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Rett Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
182 pages
Behcet Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Behcet Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
65 pages
